“Increasing the effectiveness of adherence interventions may have a far greater impact on the health of the population than any improvement in specific medical treatments.”
— World Health Organisation
Taking medicine as prescribed is not easy
Life happens, and there are many both intentional and unintentional reasons for not taking your medicine, here are some of them.
Adherence statistics
Average cost savings with 1% improved adherence in clinical trials (US dollar)
Around 40% of participants enrolled in clinical studies do not take their medicine as prescribed after the first 150 days. This leads to longer more costly trials and an increased number of participants required to keep statistical power. As shown in the table, a one per cent improvement in adherence can result in a saving of 423.000$ in costs in all trial phases. Being informed about the participant's adherence level enables a faster dose selection. The dosing regimen selection is a leading reason for delays in the regulatory approval of a drug.
References: M.Alsumidaie (2017) Non-Adherence: A Direct Influence on Clinical Trial Duration and Cost
Clinical trials
Today’s cost of non-adherence
Poor adherence leads to fewer days of treatment, unnecessary treatment switches and large financial losses. On a global scale, non-adherence is estimated to reach an avoidable cost of 171 billion US dollars per year for the healthcare system.
References: T.Aitken et al. (2012) Advancing the Responsible Use of Medicines: Applying Levers for Change
Medical treatment
“
Without any objective measurement of drug compliance, physicians have become used to opting almost always...for enhancing doses or prescribing new drug combinations... However, there is usually no rational basis for this decision.
As Burnier et al.
33%-69% of medication-related hospital admission are caused by non-adherence.
Patient health
Not taking medication as prescribed leads to poor health outcomes. Only in the United States, non-adherence is associated with 125 000 deaths, 10% of hospitalisations and $100 billion in healthcare services annually. Globally,
non-adherence is estimated to cause 33% to 69% of medication-related hospital admission.
References: V.Kini and P.M Ho (2018) Interventions to Improve Medication Adherence: A review, L.Osterberg and T.Blaschke (2005) Adherence to Medication
Among patients with chronic illnesses, 50% do not take medications as prescribed.
Chronic diseases
Treatment of chronic illnesses commonly includes long-term medication. Although these medications are effective, their full benefits are often not realised because approximately 50% of patients do not take their medicine as prescribed. This leads to increased illness and death and is estimated to result in costs of $100 billion per year.
References: M.T Brown and J.K Bussell (2011) Medication Adherence: WHO Cares?
Failure to confirm efficacy,
example: HIV therapy
When self-reporting, 90% of patients reported that they adhere to treatment. When pill counting it was revealed that only 86% of the patients were adhering to their treatment. After taking plasma samples through blood tests the percentage of patients that were adherent dropped to 30%. A far less percentage than what was reported by the patients themselves originally.
Reference: M.Burnier (2019) Is there a threshold for medication adherence? Lessons learnt from electronic monitoring of drug Adherence
Adherence based on self-reports
Adherence based on returned products counts
Adherence-based plasma samples through blood tests